Praxis Precision Medicines jobs

Medical Science Liaison - Epilepsies United States - Remote Location: This position may be performed remotely, but requires the flexibility and willingness to travel as needed. The Opportunity Praxis is seeking a field-based Medical Science Liaison (MSL) to support Medical Affairs activities for relutrigine during pre-launch and potential launch. This role is focused on building trusted scientific partnerships with a defined set of high-priority academic and community neurology centers, delivering high-quality scientific exchange, and generating actionable insights to inform medical strategy and ensure clinical readiness. This is a field-facing, development-oriented role operating within a highly focused engagement model, where you will engage healthcare professionals managing rare and developmental epilepsies. You will communicate emerging clinical data, deepen disease state understanding, and identify unmet needs and potential barriers to patient care. Working closely with internal, cross-functional partners to support aligned and compliant execution of pre-launch and launch activities in a dynamic and evolving environment. Success in this role requires strong scientific curiosity, effective communication skills, and the ability to engage in complex clinical discussions while continuing to build confidence and independence in the field. Primary Responsibilities Build and maintain scientific relationships with healthcare professionals, investigators, and key opinion leaders at a defined set of priority academic and community neurology centers Deliver accurate, balanced, and compliant scientific exchange on disease state, clinical data, and the relutrigine clinical profile, including complex discussions in rare and genetic epilepsies Support pre-launch medical readiness by educating stakeholders on emerging data, evolving treatment paradigms, and patient identification considerations

Director, Patient Support Program Operations United States - Remote Location: This position may be performed remotely, but requires the flexibility and willingness to travel as needed. The Opportunity Praxis is preparing for its first commercial launch. The Director, PSP Operations will partner closely with the Head of Patient Services to operationalize the Relutrigine Patient Support Program and stand up the internal HUB ahead of approval. This is a builder-operator role. You will translate strategy into execution, standing up workflows, pressure-testing processes, and ensuring systems, teams, and partners are ready for launch. You will serve as the operational integrator across HUB, field teams, and partners to ensure every patient touchpoint is seamless, compliant, and reliable. Experience in rare disease and internal HUBs is required for this role. You will own day-to-day HUB execution, including case management operations, workflow integrity, and performance management. This includes building and refining intake pathways and process flows, SOPs, training, and quality controls of the case management team to enable consistent, high-quality execution. Previous experience managing a case manager team is required. A critical part of this role is applying strong technology judgment, leveraging CRM platforms, and tools to improve efficiency, data quality, and patient experience in practical, compliant ways to enable an exceptional HUB experience. You are curious and proactive, comfortable testing new approaches while maintaining a high bar for patient safety and compliance and know when to pilot versus scale proven solutions. Primary Responsibilities Operationalize the HUB: Stand-up core PSP operations including intake pathways, process

National Director, Patient Education Liaison United States - Remote National Director, Patient Education Liaison Location: Remote, United States (Travel Required) Position Summary At Praxis, we believe patients and caregivers deserve more than access to innovative therapies-they deserve a trusted partner throughout their treatment journey. The National Director, Patient Education Liaison (PEL) will build, lead, and develop a field-based team responsible for supporting patients and caregivers from prescription through treatment initiation and beyond. The PEL team serves as a trusted educational resource while also helping patients and families navigate access-related challenges that may delay or disrupt treatment. Working closely with healthcare providers, Patient Services, specialty pharmacies, Market Access, and internal cross-functional partners, the PEL team helps ensure patients understand their therapy, know what to expect throughout the treatment journey, and receive timely support when barriers arise. This leader will establish the vision, strategy, capabilities, and performance standards for the Patient Education Liaison organization while creating an exceptional experience for patients, caregivers, and healthcare providers. Primary Responsibilities Build and Lead the Patient Education Liaison Team Build, lead, and develop a high-performing field-based team of Patient Education Liaisons. Establish the strategy, operating model, performance expectations, and development plans for the organization. Create a culture aligned with Praxis values of Trust, Ownership, Curiosity, and Results. Recruit, coach, and retain exceptional talent. Enhance the Patient and Caregiver Experience Develop and execute strategies that improve patient and caregiver education, confidence, and treatment readiness. Ensure consistent, high-quality patient engagement across the treatment journey. Oversee the development and

General Application Open We're always looking for great talent to join the Praxis team. From entry to Partner level, we would love to hear more about your experiences and where you have interest in contributing to the mission and community of Praxis. Complete the application below and upload your resume and cover letter. Then hit Submit Application .

Director, Community Systems New York, NY About Praxis Praxis began in 2011 with a desire to support and equip Christian entrepreneurs and has grown steadily into a 25+ person, NY-centric team advancing the redemptive quests of founders, funders, and innovators motivated by their faith to address the major issues of our time. As a $12M+/year nonprofit with ambitious growth plans, we're expanding our venture-building work globally, organizing around the major issues of our time, and building media and more to activate the redemptive potential of Christians around the world. We see our team as the first carriers of the mission, building an organization that is great to work at, excellent in its craft, and redemptive in its finances as well as its programs. Hear more about this role from Dan Reed, the Partner, Capital. The Role This role reports to Dan Reed, the Partner, Capital at Praxis. As Director, Community Systems, you will lead a senior strategic role responsible for building and stewarding the systems, data infrastructure, and communications workflows that power Praxis's community at scale. This is not a traditional “operations” role - it is a community architecture role, designed for someone who understands that a healthy ecosystem requires healthy systems. Praxis cultivates a dense, global network of founders, funders, venture builders, thinkers, and creatives. The Director, Community Systems is responsible for owning the systems and tools that underpin the community's ability to connect and work on shared projects together, while building the workflows that allow Praxis to be

Associate, Global Events & Operations New York, NY About Praxis Praxis began in 2011 with a desire to support and equip Christian entrepreneurs and has grown steadily into a 25+ person, NY-centric team advancing the redemptive quests of founders, funders, and innovators motivated by their faith to address the major issues of our time. As a $12M+/year nonprofit with ambitious growth plans, we're expanding our venture-building work globally, organizing around the major issues of our time, and building media and more to activate the redemptive potential of Christians around the world. We see our team as the first carriers of the mission, building an organization that is great to work at, excellent in its craft, and redemptive in its finances as well as its programs. About the Role Our work operates across several interconnected areas: our Accelerator programs identify and form the most exceptional redemptive entrepreneurs in the US, Africa, and Asia-Pacific through intensive cohort experiences and long-term community; our Regional Gatherings bring together the top founders, funders, builders, thinkers, and creatives in a region to awaken their redemptive imagination; and our local ecosystems work trains and develops city ecosystem leaders across 120 cities to host Praxis experiences, including a new Praxis Course, Redemptive Imagination Tables, and three-day Labs. We are deepening our investment in the cities and regions most ready to become self-sustaining centers of redemptive entrepreneurship. Underlying all of our work is a conviction that human flourishing at scale is built through dense networks of formative friendships aimed

Manager, Local Ecosystems New York, NY About Praxis Praxis began in 2011 with a desire to support and equip Christian entrepreneurs and has grown steadily into a 25+ person, NY-centric team advancing the redemptive quests of founders, funders, and innovators motivated by their faith to address the major issues of our time. As a $12M+/year nonprofit with ambitious growth plans, we're expanding our venture-building work globally, organizing around the major issues of our time, and building media and more to activate the redemptive potential of Christians around the world. We see our team as the first carriers of the mission, building an organization that is great to work at, excellent in its craft, and redemptive in its finances as well as its programs. About the Role Our work operates across several interconnected areas: our Accelerator programs identify and form the most exceptional redemptive entrepreneurs in the US, Africa, and Asia-Pacific through intensive cohort experiences and long-term community; our Regional Gatherings bring together the top founders, funders, builders, thinkers, and creatives in a region to awaken their redemptive imagination; and our local ecosystems work trains and develops city ecosystem builders across 120 cities to host Praxis experiences, including a new Praxis Course, Redemptive Imagination Tables, and three-day Labs. Underlying all of our work is a conviction that human flourishing at scale is built through dense networks of formative friendships aimed at a common vision, and that conviction animates our Global Venture Building Ecosystem (GVBE) strategy. The GVBE team is responsible for

Medizinische Fachangestellte (m/w/d) für die nephrologische Praxis Aalen, Germany posted: Posted 14 Days Ago

StudiumPLUS Praxis – Artificial Intelligence in Engineering Sciences (B.Eng., M/F/D) Germany-Waldbronn posted: Posted 30+ Days Ago

Duales Studium mit vertiefter Praxis (Master m/w/d) Wackersdorf, Bavaria posted: Posted 30+ Days Ago

Director, Precision Medicine (Cell Medicine) 2 Locations posted: Posted 4 Days Ago

Director, Head of Product Management – AI-Enabled Precision Medicine (Therapeutics & Innovations) US Remote Director, Head of Product Management - AI-Enabled Precision Medicine (Therapeutics & Innovations) About Us We are redefining the future of precision medicine by integrating AI with healthcare to create next-generation, precision treatment modalities. Our multidisciplinary team is building products at the intersection of clinical data, multi-omics, and machine learning-unlocking entirely new approaches to drug development and patient care. Within the Therapeutics & Innovations Business Unit, we are developing a new category that bridges diagnostics and therapeutics. Our platform combines deep scientific expertise with proprietary datasets to power AI-enabled solutions that can transform how therapies are discovered, developed, and deployed. We are looking for a product leader who can translate this potential into real, scalable products-owning the strategy, roadmap, and execution to bring these innovations to market. The Role We are seeking a Director / Head of Product Management to lead product strategy and execution for our AI-enabled therapeutics platform. This is a highly cross-functional leadership role at the center of science, engineering, clinical development, and commercial strategy. You will define what we build, why it matters, and how it creates value-for biopharma partners, clinicians, and ultimately patients. You will own the product lifecycle end-to-end: from concept and validation through development, launch, and iteration. This role requires a rare blend of scientific fluency, product rigor, and commercial instinct . You will work closely with R&D, AI, medical, business development, and marketing to ensure our products are scientifically

Manager Precision Medicine 2 Locations posted: Posted 4 Days Ago

Director Precision Medicine 2 Locations posted: Posted 4 Days Ago

Director, Computational Biology, Precision Medicine India - Hyderabad posted: Posted Yesterday

Precision Medicine Director Barcelona Barberà posted: Posted 4 Days Ago

Data Science Consultant - Precision Medicine Tokyo, Tokyo, Japan Are you experienced in data science and passionate about precision medicine? Join our team as a Data Science Consultant and leverage your expertise to drive innovation in biopharma R&D. Collaborate with leading scientists and make a real impact in the life sciences industry.

Associate Director, Precision Medicine 2 Locations posted: Posted 4 Days Ago

Senior Software Engineer, Precision Medicine India - Hyderabad posted: Posted 30+ Days Ago

Senior Director, Biostatistics, Europe Remote (Switzerland) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Playing a critical role as a lead statistician for clinical program(s) and the subject matter expert (SME) in Biostatistics within the Quantitative Sciences function, this position is to provide statistical leadership and support for EU access strategies, healthcare technology assessments and regulatory submissions. - Serve as the statistical lead for European access strategies, ensuring alignment between Global Clinical Development, European regulatory (EMA, MHRA, Swissmedic...) and regional/local Market Access needs to support successful European launches in collaboration with global and regional crossfunctional teams. - Partner with Regional and Local Market Access and HEOR functions to design and lead/oversee the execution of statistical analyses required for value dossiers, including PICO, indirect treatment comparisons, network meta-analyses, and RWE generation. - Partner closely with the development statistical lead, provide statistical support for EU regulatory interactions, including EMA Scientific Advice, MAA, Type II variations, and post-authorization commitments. - Ensure statistical methodologies

Principal Machine Learning Scientist, Drug Discovery Analytics Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a Principal Machine Learning Scientist to lead the development of advanced machine learning approaches that accelerate small-molecule drug discovery. This role sits at the intersection of data science, chemistry, and biology, transforming complex scientific datasets into predictive models that guide target discovery, compound design, and translational hypotheses. Working closely with experimental scientists, the Principal ML Scientist will develop cutting-edge modeling approaches that integrate chemical, biological, and phenotypic data. The successful candidate will play a key role in advancing a data-driven discovery strategy by designing predictive models, deploying innovative algorithms, and translating insights into actionable decisions that improve the speed and success of the discovery of medicines for patients with RAS-driven cancers. Key responsibilities include: Scientific Leadership: - Define and lead machine learning strategies that accelerate early-stage drug discovery. - Identify opportunities where AI and advanced analytics can

Director, Medical Analytics and Exploratory Data Science Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a highly motivated and scientifically rigorous Director of Biostatistics to our Medical Analytics and Exploratory Data Science Biostatistics group. This role will provide strategic and hands-on statistical leadership for exploratory data analyses, scientific publications, real-world evidence (RWE), post-marketing research, and health economics and outcomes research (HEOR) initiatives. The successful candidate will serve as a key statistical leader and individual contributor, partnering closely with cross-functional teams to generate high-quality evidence that advances our oncology pipeline and supports medical and scientific strategy. - Provide statistical leadership for exploratory data analyses using existing clinical trial data, real world data studies, post-marketing research, and HEOR projects. - Serve as a primary statistical contact for assigned projects, working collaboratively with clinical development, medical affairs, safety, statistical programming, regulatory affairs and commercial. - Lead the design, analysis, and interpretation of complex statistical models,

Senior Director, Real World Data & Analytics Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director, Real-World Data & Analytics will work with the Executive Director, Head of Epidemiology and VP of HEOR to establish the RWD&A group at RevMed, scaling organizational capabilities and leading the strategy and execution of key RWD&A deliverables for RevMed assets. They will be accountable for working across the clinical development, safety, medical affairs, commercial including analytics and insights, and IT matrix, developing strategies and leading and/or overseeing execution of key projects. Reporting to the Executive Director, Head of Epidemiology & RWD Strategy, they will closely align with the other users of RWD at RevMed, develop ways of working and communication channels to maximize RevMed's investment in RWD as well as lead the analysis (either directly or leveraging junior team members and vendors) of RWD database and other studies. This is an exceptional opportunity to contribute to the advancement of

Senior Scientist I, Clinical Biomarker Development Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Scientist I in Clinical Biomarker Development team, within the Translational Medicine will play a key role in the design, execution, and interpretation of clinical biomarker strategies across Revolution Medicine's oncology pipeline. You will: - Design and execute clinical biomarker strategies to support early response monitoring, patient stratification, and understanding resistance mechanisms. - Support biomarker implementation for early- and late-stage oncology clinical trials. - Oversee biomarker assay development, qualification, and sample analysis in collaboration with internal teams and external CROs. - Analyze and interpret biomarker data in the context of clinical outcomes and present results to cross-functional teams. - Contribute to clinical protocols, study reports, and regulatory documents (e.g., INDs, IBs, CSRs). - Translate preclinical findings into clinically actionable biomarker hypotheses. - Stay current with emerging biomarker technologies and trends in precision oncology. Required Skills, Experience and Education: - PhD